Skip to main content
. 2021 Jan 9;304(2):511–519. doi: 10.1007/s00404-020-05949-w

Table 3.

Analysis of patient’s characteristics and postoperative complications

Complications
Characteristics
Lymphocele (n = 17) Lymphedema (n = 10) Wound breakdown (n = 22) Total (n = 121) p value
BMI (kg/m2) 28.4 ± 6.5 26.7 ± 5.5 30.5 ± 7.4 27.5 ± 6.1 n.s
Age (years) 75.6 ± 10.0 70.9 ± 12.9 74.4 ± 11.4 69.4 ± 15.3 n.s
Nicotine abuse (n) 4 (23.5%) 1 (10%) 1 (4.5%) 36 (29.8%)
Lichen sclerosis (n) 1 (5.9%) 0 2 (9.1%) 21 (17.4%)
Arterial hypertension (n) 14 (82.4%) 6 (60%) 20 (90.9%) 67 (55.4%)
VIN III (n) 4 (23.5%) 3 (30%) 4 (18.2%) 46 (38%)
Number of resected lymph nodes 17.5 ± 15* 20.6 ± 20* 21–5 ± 17.7* 13.7 ± 11.6  < 0.01
Duration of surgery (minutes) 170.6 ± 77.2 180.2 ± 84.8 196.5 ± 121.5* 119.4 ± 84.7 0.01
Multifocal tumor (n) 3 (17.6%) 3 (30%) 7 (31.8%) 25 (20.7%)
Lymphatic invasion (n) 2 (11.8%) 0 5 (22.7%) 12 (9.9%)
Average depth of invasion (mm) 6.9 ± 5.8 10.5 ± 12.8 11.0 ± 10.3* 5.7 ± 7.0 0.01
Resection margin (mm) 5.2 ± 3.9 4.8 ± 4.6 3.6 ± 3.0 4.8 ± 3.4
Radiation therapy (n) 4 (23.5%) 6 (60%) 9 (40.9%) 19 (15.7%)
Chemotherapy (n) 0 0 2 (9.1%) 3 (2.5%)
ECOG (average) 1.5 1.2 1.7 1.1
Duration of treatment in the hospital (days) 12.5 ± 6.7 12.6 ± 8.1 19.6 ± 15.2 9.7 ± 9.1
FIGO I and II (n) 11 (64.7%) 4 (40%) 12 (54.5%) 95 (78.5%)
FIGO III and IV (n) 6 (35.3%) 6 (60%) 10 (45.5%) 26 (21.5%)

p values calculated via ANOVA

*Significant differences